Associate Director, MS&T

Ray Therapeutics mission is to restore vision to people with retinal degenerations. RayTx is using a novel bioengineered optogenetic protein optimized for human vision delivered by AAV to restore visual function in a mutation agnostic approach and without the need for light enhancing eyewear. The company is developing its lead candidate RTx-015 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need as well as a pipeline to treat both rare and large market indications. We are currently seeking an exceptional leader as Associate Director, Manufacturing Sciences and Technology (MS&T) to join our team in the mission to restore vision to patients. The Associate Director, MS&T will work closely with and report to our VP, CMC in all aspects of manufacturing from early phase through late phase/commercial manufacturing. The position requires hands on AAV manufacturing experience with the ability to be a team player both internally as well as with our external partners. Essential Duties and Responsibilities: Build internal manufacturing tracking and trending system including in-process and release testing results as well as manufacturing process parameters and raw materials. Collaborate with internal CMC team (Product Management and Analytics) and external vendors to obtain information for tracking and trending information. Present quarterly summary report for CMC Leadership and external vendors on trending and statistical analyses. Provide technical and process engineering input into RayTx’s CMC product lifecycle strategies including early phase, late phase and commercial development, manufacturing, and regulatory compliance activities. Proactively outline risk and mitigations and communicate all to internal team. In collaboration with CMC Leadership, provide regular updates to leadership team on progress, data, risks, and forecasting of future CMC project needs. Qualifications and Experience: Bachelors degree in relevant scientific or engineering discipline. 10+ years relevant biotech experience. Hands on experience in AAV gene therapy manufacturing required. Knowledge of AAV analytical methods and testing. 5+ years of experience working with JMP, Minitab or other statistical software for biological product manufacturing and testing. Experience with manufacturing tracking and trending or statistical process control. Knowledge of AI or software that can extract data from PDFs into tracking and trending database. Excellent scientific knowledge and acumen. Ability to travel up to 20% Compensation Range and Benefits: For this role, the anticipated base salary range: $170,000 to $190,000, based on the candidate's professional experience level. The final salary offered for this position may take into account a number of factors including, but not limited to skills, education, and experience. Ray Therapeutics also offers annual performance-based bonus, annual equity awards and a comprehensive benefits package. At Ray Therapeutics, we celebrate diversity and are committed to creating an inclusive environment for all employees; providing an environment of mutual respect where equal employment opportunities are available to all applicants and teammates without regard to race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. All employment is decided on the basis of qualifications, merit, and business need. Search Firm Representatives Please Read Carefully Ray Therapeutics does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Please, no phone calls or emails.

Created: 2026-03-11